## Core Concept
Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the substantia nigra, leading to motor symptoms such as tremors, rigidity, and bradykinesia. The treatment aims to alleviate these symptoms by either increasing dopamine levels or mimicking its action in the brain. Various pharmacological agents are used to manage Parkinson's disease.

## Why the Correct Answer is Right
The correct answer, , includes drugs that are well-established in the treatment of Parkinson's disease. Levodopa (combined with carbidopa) is a precursor to dopamine and increases dopamine levels in the brain. Dopamine agonists like pramipexole and ropinirole mimic the action of dopamine. MAO-B inhibitors, such as selegiline and rasagiline, prevent the breakdown of dopamine. COMT inhibitors, like entacapone, also increase dopamine availability by preventing its degradation. These classes of drugs directly address the dopaminergic deficiency seen in Parkinson's disease.

## Why Each Wrong Option is Incorrect
- **Option A:** - This option might include drugs not primarily used for Parkinson's disease or might be incorrect in the context of the provided options.
- **Option B:** - Similarly, this could include less relevant or incorrect drugs for Parkinson's treatment.
- **Option D:** - This option might list drugs that are not typically used for managing Parkinson's disease symptoms.

## Clinical Pearl / High-Yield Fact
A key point to remember is that while levodopa is very effective, its long-term use is associated with complications like motor fluctuations and dyskinesias. Therefore, the management of Parkinson's disease often involves a combination of drugs to optimize symptom control and minimize side effects.

## Correct Answer Line
**Correct Answer: .**